PrescriptionDrugs.org

Hydrochlorothiazide

Brand names: Microzide

Thiazide Diuretics

Key Takeaway

Hydrochlorothiazide (HCTZ) is a thiazide diuretic FDA-approved for high blood pressure (hypertension) and edema. One of the oldest and most prescribed blood pressure medications, it works by helping your kidneys remove excess salt and water from the body, lowering blood pressure. It is taken once daily and is often used in combination with other antihypertensives.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

How does Hydrochlorothiazide work?

Hydrochlorothiazide belongs to the thiazide diuretic class of medications. To understand how it works, it helps to know a little about how your kidneys handle salt and water [1, 2].

Your kidneys filter your entire blood volume approximately 60 times per day. As blood passes through the kidneys, useful substances are reabsorbed back into the bloodstream while waste products are excreted in urine. In one section of the kidney tubules — called the distal convoluted tubule — a transporter called the sodium-chloride cotransporter (NCC) reabsorbs sodium and chloride from the urine back into the blood [1, 12].

Hydrochlorothiazide blocks this NCC transporter, preventing the kidneys from reabsorbing sodium and chloride at this site. When sodium stays in the urine, water follows it (due to osmosis), leading to increased urine production. This reduces the volume of fluid in your blood vessels, which lowers blood pressure [1, 2, 10].

However, the diuretic effect alone does not fully explain HCTZ's blood pressure-lowering action. After several weeks of treatment, the blood volume returns toward normal, but blood pressure remains lower. This is because HCTZ also causes vasodilation — relaxation of blood vessel walls — through mechanisms that are not completely understood but may involve reduced vascular reactivity to vasoconstrictors like norepinephrine and angiotensin II [1, 10, 12].

HCTZ has been in clinical use since 1959, making it one of the longest-used prescription medications. Its effectiveness, safety profile, and extremely low cost have made it a cornerstone of hypertension treatment for over six decades [1, 3, 4]. The ALLHAT trial — one of the largest hypertension trials ever conducted — demonstrated that thiazide diuretics are at least as effective as newer, more expensive antihypertensives for preventing cardiovascular events [3].

The onset of diuresis occurs within 2 hours of a dose, peaks at 4-6 hours, and the diuretic effect lasts 6-12 hours. Full antihypertensive effect may take 2-4 weeks to develop [1, 4, 10].

What to expect when starting Hydrochlorothiazide

When you start HCTZ, you will notice increased urination, particularly in the first few hours after taking your dose. This is the intended diuretic effect. Most people find that taking HCTZ in the morning (before noon) prevents nighttime bathroom trips [1, 4].

During the first few days to weeks, the increased urination can cause mild dehydration symptoms — dry mouth, increased thirst, and occasional dizziness, especially when standing up quickly (orthostatic hypotension). These effects usually lessen as your body adjusts [1, 9].

Blood pressure reduction begins within the first week, but the full antihypertensive effect takes 2-4 weeks to develop [1, 4, 10]. Your doctor will check your blood pressure periodically to assess response.

A critical aspect of HCTZ therapy is electrolyte monitoring. HCTZ causes your kidneys to excrete potassium along with sodium. Low potassium (hypokalemia) can cause muscle cramps, weakness, fatigue, and — in severe cases — dangerous heart rhythm abnormalities [1, 9]. Your doctor will check your blood electrolytes (potassium, sodium, magnesium) within the first few weeks and periodically thereafter [1, 4].

To help maintain potassium levels, your doctor may recommend eating potassium-rich foods (bananas, oranges, potatoes, spinach), prescribe a potassium supplement, or add a potassium-sparing diuretic [1, 9].

HCTZ increases sensitivity to sunlight (photosensitivity) and has been associated with an increased risk of non-melanoma skin cancer with long-term use [6, 7]. Use sunscreen and protective clothing when outdoors.

What are the common side effects of Hydrochlorothiazide?

Common

Common(12 effects)
  • Increased urination (polyuria)Common in first days/weeks
  • Dizziness/lightheadedness5-10%
  • Electrolyte imbalance (hypokalemia)10-40% have some potassium decrease; clinically significant in 5-10%
  • Increased uric acid (hyperuricemia)Up to 50% have some increase; gout precipitation in 2-5%
  • Photosensitivity (sun sensitivity)5-10%
  • Muscle cramps5-10%
  • Nausea3-5%
  • Fatigue/weakness5-8%
  • Increased blood glucoseModest increase in glucose/HbA1c; new diabetes in 1-3% over several years
  • Increased cholesterol/triglycerides2-7% increase in LDL and triglycerides (generally transient)
  • Erectile dysfunction3-5%
  • Headache3-5%

What are the serious side effects of Hydrochlorothiazide?

Serious

Serious(6 effects)
  • Severe hypokalemia1-5% clinically significant; can cause cardiac arrhythmias
  • Hyponatremia1-5%; more common in elderly women
  • Acute kidney injuryRare; usually related to volume depletion
  • Severe allergic reactions (anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis)Very rare
  • PancreatitisVery rare
  • Non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)Modest increased risk with cumulative high-dose exposure (FDA warning 2020)

What drugs interact with Hydrochlorothiazide?

  • Major
    Lithium Thiazide diuretics reduce lithium clearance and can increase lithium levels to toxic concentrations. If the combination is necessary, monitor lithium levels frequently and reduce lithium dose as needed. Signs of toxicity include tremor, nausea, confusion, and ataxia.
  • Major
    Digoxin HCTZ-induced hypokalemia increases the risk of digoxin toxicity, which can cause life-threatening cardiac arrhythmias. Monitor potassium levels closely and maintain them within normal range when using this combination.
  • Moderate
    NSAIDs (ibuprofen, naproxen, meloxicam) NSAIDs can reduce the antihypertensive and diuretic effects of HCTZ by inhibiting renal prostaglandin synthesis. The combination also increases the risk of acute kidney injury, especially in volume-depleted or elderly patients. Avoid if possible or monitor renal function and blood pressure.
  • Moderate
    ACE inhibitors and ARBs (lisinopril, losartan) Commonly used in combination for blood pressure control. However, the combination can cause excessive potassium loss or (with ACE-I/ARB) potassium retention. First-dose hypotension can occur. Monitor electrolytes and blood pressure. Triple combination (HCTZ + ACE-I + ARB) is not recommended.
  • Moderate
    Antidiabetic medications (insulin, sulfonylureas, metformin) HCTZ can increase blood glucose levels, potentially reducing the effectiveness of antidiabetic medications. Monitor blood glucose more frequently when starting HCTZ in diabetic patients. Dose adjustments of antidiabetic drugs may be needed.
  • Moderate
    Potassium-depleting drugs (loop diuretics, corticosteroids, amphotericin B) Concurrent use with other potassium-depleting drugs increases the risk of severe hypokalemia. Monitor potassium levels closely. Potassium supplementation may be necessary.
  • Moderate
    Cholestyramine and colestipol These bile acid sequestrants can bind HCTZ in the gastrointestinal tract, reducing its absorption by up to 85%. Take HCTZ at least 1 hour before or 4 hours after cholestyramine/colestipol.
  • Moderate
    Alcohol Alcohol can potentiate the orthostatic hypotension caused by HCTZ, increasing the risk of dizziness and fainting. Use with caution, especially during the first few weeks of treatment.

View all drug interactions →

Can I eat certain foods or drink alcohol with Hydrochlorothiazide?

HCTZ can be taken with or without food. Taking it with food may reduce mild nausea [1, 2].

Alcohol can worsen the blood pressure-lowering and dehydrating effects of HCTZ, increasing the risk of dizziness and fainting, especially when standing up [1]. Limit alcohol consumption, particularly in the first few weeks of treatment.

Potassium-rich foods (bananas, oranges, potatoes, spinach, tomatoes, avocados) can help offset HCTZ's potassium-depleting effect [1, 9]. Your doctor may recommend increasing dietary potassium or prescribing a potassium supplement.

Stay well-hydrated, especially in hot weather or during exercise. HCTZ increases water loss through urination, and dehydration can worsen electrolyte imbalances and cause dizziness or kidney problems [1, 9].

Salt (sodium) intake should be moderate. While HCTZ helps remove excess sodium, excessive salt intake can counteract the blood pressure-lowering effect [1, 4]. The DASH diet, which emphasizes fruits, vegetables, whole grains, and reduced sodium, is recommended as a complementary approach to pharmacological blood pressure control [4].

What is the typical dosage for Hydrochlorothiazide?

Hypertension [1, 4, 10]: - Starting dose: 12.5-25 mg once daily - Usual dose: 25 mg once daily - Maximum dose: 50 mg once daily (higher doses provide minimal additional blood pressure reduction but significantly increase side effects) - Most guidelines recommend 12.5-25 mg as the optimal dose range for hypertension [4, 10]

Edema [1]: - Starting dose: 25-50 mg once or twice daily - Maximum dose: 100 mg/day (in divided doses if >50 mg)

Available forms [1]: - Tablets: 12.5 mg, 25 mg, 50 mg - Capsules (Microzide): 12.5 mg - Also available in numerous fixed-dose combinations with other antihypertensives (lisinopril/HCTZ, losartan/HCTZ, valsartan/HCTZ, amlodipine/valsartan/HCTZ, etc.)

Timing: Take in the morning to avoid nighttime urination [1]

Renal impairment: Generally ineffective when GFR <30 mL/min (switch to a loop diuretic). Contraindicated in anuria [1]. Hepatic impairment: Use cautiously; can precipitate hepatic encephalopathy in cirrhosis [1].

Elderly: Start at 12.5 mg; higher risk of electrolyte abnormalities, especially hyponatremia [1, 9]

Key monitoring [1, 4, 9]: Check serum potassium, sodium, magnesium, creatinine, BUN, uric acid, and glucose at baseline, 2-4 weeks, then periodically

How much does Hydrochlorothiazide cost?

Hydrochlorothiazide is one of the least expensive prescription medications available [1, 11]. A 30-day supply typically costs $3-$8 at most pharmacies, even without insurance.

Many pharmacy chains include HCTZ on their $4 generic drug lists (Walmart, Kroger, Costco, and others) [11]. With a GoodRx coupon, prices may be even lower.

All insurance plans (Medicare, Medicaid, commercial) cover generic HCTZ with minimal or no copay. It is one of the most cost-effective medications in all of medicine [3, 11].

Brand-name Microzide (12.5 mg capsule) is rarely prescribed. Generic HCTZ tablets are universally available and therapeutically equivalent [1, 8].

Combination products (HCTZ + another antihypertensive in one pill) are also available as generics at low cost, offering convenience without added expense. Common combinations include lisinopril/HCTZ, losartan/HCTZ, and valsartan/HCTZ — all available as affordable generics [11].

Is Hydrochlorothiazide safe during pregnancy or breastfeeding?

Pregnancy: Hydrochlorothiazide crosses the placenta [1]. Thiazide diuretics are generally not recommended during pregnancy because they can reduce placental perfusion and cause fetal/neonatal complications including jaundice, thrombocytopenia, hyponatremia, hypokalemia, and hemolytic anemia [1, 12]. Unlike preeclampsia treatment (where diuretics may worsen the condition by reducing already-compromised blood volume), HCTZ use in pregnancy is generally avoided. If blood pressure treatment is needed during pregnancy, medications with better safety data (labetalol, nifedipine, methyldopa) are preferred [1, 4].

Breastfeeding: HCTZ is excreted in breast milk. Thiazide diuretics can suppress lactation [1]. The estimated relative infant dose is approximately 2-4% of the weight-adjusted maternal dose. While serious adverse effects in breastfed infants are unlikely, use the lowest effective dose and monitor the infant for adequate milk supply and electrolyte-related symptoms. Alternative antihypertensives with better breastfeeding safety data may be preferred [1, 12].

Is there a generic version of Hydrochlorothiazide?

Hydrochlorothiazide has been available as a generic for decades. Brand-name Microzide (12.5 mg capsule) is rarely dispensed [1, 8].

All generic HCTZ products are AB-rated by the FDA as therapeutically equivalent. There is no clinically meaningful difference between any generic manufacturer's product [1, 8].

HCTZ is so inexpensive as a generic ($3-$8/month) that brand-name products serve no practical purpose [11]. The cost difference is negligible.

Numerous fixed-dose combination products containing HCTZ with another antihypertensive are also available as generics, all at very low cost [11].

HCTZ vs. chlorthalidone: Some experts argue that chlorthalidone (a longer-acting thiazide-like diuretic) may be preferable to HCTZ for hypertension due to superior 24-hour blood pressure control and stronger clinical trial evidence for cardiovascular outcomes [5, 13]. However, HCTZ remains the most commonly prescribed thiazide, partly due to its availability in many fixed-dose combinations [4, 5].

For Caregivers

If you care for someone taking HCTZ, help them maintain adequate hydration, especially in hot weather. Dehydration can cause dangerous drops in blood pressure and electrolyte imbalances [1, 9].

Watch for signs of low potassium (hypokalemia): muscle cramps or weakness, excessive fatigue, irregular heartbeat, confusion. Report these to the prescriber [1, 9].

Watch for signs of low sodium (hyponatremia): confusion, lethargy, headache, nausea, seizures. This is more common in elderly patients, especially women [1, 9].

Ensure the person takes HCTZ in the morning to avoid nighttime bathroom trips and sleep disruption [1].

Remind them about sun protection. HCTZ significantly increases sun sensitivity and the risk of sunburn and non-melanoma skin cancer with long-term use [6, 7]. Use SPF 30+ sunscreen, wear protective clothing, and avoid prolonged sun exposure.

Help them attend follow-up appointments for blood pressure monitoring and blood work (electrolytes, kidney function). Regular monitoring is essential for safe long-term use [1, 4].

Frequently asked questions about Hydrochlorothiazide

References

  1. [Regulatory] Microzide (hydrochlorothiazide) capsules prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/040735s007lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Hydrochlorothiazide. National Library of Medicine DailyMed drug label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7510c28-c35a-4527-b0fa-9e0e5a5b1327 Accessed 2025-01-15.
  3. [Regulatory] ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/14656957/ Accessed 2025-01-15.
  4. [Regulatory] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115. https://pubmed.ncbi.nlm.nih.gov/29133354/ Accessed 2025-01-15.
  5. [Regulatory] Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47(3):352-358. https://pubmed.ncbi.nlm.nih.gov/22265393/ Accessed 2025-01-15.
  6. [Regulatory] FDA approves label changes for HCTZ to describe risk of non-melanoma skin cancer. 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-label-changes-hydrochlorothiazide-describe-risk-non-melanoma-skin-cancer Accessed 2025-01-15.
  7. [Regulatory] Pedersen SA, Gaist D, Schmidt SAJ, et al. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol. 2018;78(4):673-681. https://pubmed.ncbi.nlm.nih.gov/29875680/ Accessed 2025-01-15.
  8. [Regulatory] Drugs@FDA: FDA-Approved Drugs — Microzide NDA 040735. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040735 Accessed 2025-01-15.
  9. [Regulatory] Sica DA. Diuretic-related side effects: development and treatment. J Clin Hypertens. 2004;6(9):532-540. https://pubmed.ncbi.nlm.nih.gov/11926784/ Accessed 2025-01-15.
  10. [Regulatory] Musini VM, Nazer M, Bassett K, Wright JM. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev. 2014;(5):CD003824. https://pubmed.ncbi.nlm.nih.gov/25559744/ Accessed 2025-01-15.
  11. [Observational] GoodRx. Hydrochlorothiazide Prices, Coupons & Savings Tips. https://www.goodrx.com/hydrochlorothiazide Accessed 2025-01-15.
  12. [Regulatory] UpToDate. Hydrochlorothiazide: Drug information. Wolters Kluwer. https://www.uptodate.com/contents/hydrochlorothiazide-drug-information Accessed 2025-01-15.
  13. [Regulatory] Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension. 2015;65(5):1041-1046. https://pubmed.ncbi.nlm.nih.gov/28135038/ Accessed 2025-01-15.
  14. [Regulatory] Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006;48(2):219-224. https://pubmed.ncbi.nlm.nih.gov/16818819/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: